Front page/Yahoo FinanceOcular Therapeutix (OCUL) Announces Additional Positive Data From the SOL-1 Phase 3 Superiority Trial of AXPAXLIRRedacciónNewsroom · anteayer2 min readRead the full story at Yahoo Finance